Buyer's guide: Choosing an informatics platform for gene therapy R&D
This buyer's guide provides an evaluation framework for assessing the critical features that separate a modern platform from legacy software.
Gene therapy marks a new era of medicine, bringing with it a new R&D paradigm where the product is a complex combination of genetic materials and viral or non-viral delivery vectors. As a result, conventional lab informatics platforms are not always optimal for gene therapy R&D.
To help gene therapy R&D teams find an informatics platform that will efficiently advance their unique pipeline, this guide provides:
An evaluation framework which highlights critical features that separate a modern, powerful platform from legacy software and over-complicated spreadsheets
List of questions for you to ask during a platform assessment
